Ferretti, Maria Teresa
,
Iulita, Maria Florencia
Cavedo, Enrica
Chiesa, Patrizia Andrea
Schumacher Dimech, Annemarie
Santuccione Chadha, Antonella
Baracchi, Francesca
Girouard, Hélène
Misoch, Sabina
Giacobini, Ezio
Depypere, Herman
Hampel, Harald
Article History
First Online: 9 July 2018
Competing interests
: H.H. is a Senior Associate Editor for the journalAlzheimer’s & Dementia. He has received fees for lecturing from Biogen and Roche; research grants from Pfizer, Avid, and MSD Avenir (all three paid to his institution); travel funding from Axovant, Eli Lilly, Functional Neuromodulation, GE Healthcare, Oryzon Genomics and Takeda and Zinfandel; and consultancy fees from Anavex, Axovant, Cytox, Functiona Neuromoduation, GE Healthcare, Jung Diagnostics, Oryzon Genomics and Takeda and Zinfandel. He participated in scientific advisory boards of Axovant, Cytox, Eli Lilly, Functional Neuromodulation, GE Healthcare, Oryzon Genomics, Roche Diagnostics and Takeda and Zinfandel. He is a co-inventor on several patents related to markers and the diagnosis of neurodegenerative disease (numbers 8916388, 8298784, 20120196300, 20100062463, 20100035286, 20090263822, 7547553, 20080206797, 20080199966 and 20080131921) but has received no royalties. All other authors declare no conflicts of interest.